Taswell2018SDAIR
- Title
-
Safety of Disclosing Amyloid Imaging Results to MCI and AD Patients
View PDF | Save PDF - Authors
- Carl Taswell, Cheryl Donohue, Maree Mastwyk, Andrea Louey, Jacqueline Giummarra, Joanne Robertson, David Darby, Colin Masters, and Christopher Rowe
- Affiliations
- Brain Health Alliance, Ladera Ranch, California; University of California San Diego, La Jolla, California; Florey Inst Neuroscience & Mental Health, University of Melbourne, Parkville, VIC, Australia; Austin Health Dept Molecular Imaging, Melbourne, VIC, Australia
- Abstract
- Objective: To assess the psychological impact of disclosing a positive or negative amyloid brain scan result to symptomatic individuals with mild cognitive impairment (MCI) or mild Alzheimer's disease (AD). Design: Prospective longitudinal cohort study. Setting: Florey Institute of Neuroscience & Mental Health, University of Melbourne, Australia. Participants: A total of 133 individuals aged 50-85 with MCI or mild AD enrolled in the study with data collected between October 2014 and June 2016. Interventions: Disclosure of amyloid imaging results to participants. Measurements: Positron emission tomography (PET) brain amyloid imaging with [18F]-NAV4694; psychometric scales including the Center for Epidemiologic Studies Depression (CES-D) scale, Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scales (HADS-A and HADS-D) and State-Trait Anxiety Inventory (STAI) performed before and after disclosure of amyloid imaging results. Results: We did not observe any worsening of psychological health with a panel of psychometric scales assessed on individuals to whom amyloid brain scan results were disclosed. Conclusions: We consider it safe, without apparent risk of harm to patients, to disclose amyloid imaging results to patients who have no prior history of neuropsychiatric illness.
- KeyPhrases
- Alzheimer's disease, dementia, mild cognitive impairment, PET scan, brain amyloid imaging, risk disclosure, results disclosure.
- Dates
- published 2018-09-03, reprinted 2023-06-25.
- Citation
-
Brainiacs Journal 2023 Volume 4 Issue 1 Edoc
DOI: 10.48085/X661B91A3
PDP: Nexus/Brainiacs/Taswell2018SDAIR
URL: BrainiacsJournal.org/arc/pub/Taswell2018SDAIR
2020v1i1 | 2021v2i1 | 2022v3i1 | 2022v3i2 | 2023v4i1 | 2023v4i2 | 2024v5i1 | 2024v5i2